FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017888462> ?p ?o ?g. }

• W2017888462 abstract "This article attempts to provide the reader with a complete overview of topoisomerase (topo) II alpha as a marker for predicting the efficacy of anthracyclines in patients with breast cancer. In the first section of this article, in vitro data supporting the predictive value of topo II alpha are reviewed. Interestingly, these data suggest that the interaction between HER2 and anthracycline efficacy, which has been hypothesized in several clinical studies performed in the past decade, might depend on the concomitant topo II alpha status. Molecular pathology studies further reinforce the concept that HER2 might not be directly involved in the prediction of response to anthracyclines. They report that topo II alpha gene amplification can be found in 25%-40% of HER2/neu-amplified tumors, while no topo II gene amplification is detected in the absence of HER2/neu gene amplification. In the second part of this article, a series of clinical studies are reviewed and interpreted. These studies have attempted to correlate topo II alpha status with anthracycline efficacy in the adjuvant, neoadjuvant, and metastatic settings. All of the studies evaluating the topo II alpha gene suggest that gene amplification might be associated with an increased efficacy of anthracyclines, and some of the studies evaluating topo II alpha protein find that protein overexpression might correlate with an increased sensitivity to these compounds. Despite these findings, however, the reported studies do not provide the proof of principle needed to authorize the use of topo II alpha as a predictive marker for standard practice. A new generation of research is currently testing the predictive value of topo II alpha. It is hoped that these projects, which are described in the last section of the article, will clarify the role of topo IIa in the prediction of response to anthracyclines." @default.
• W2017888462 created "2016-06-24" @default.
• W2017888462 creator A5041495974 @default.
• W2017888462 creator A5068108014 @default.
• W2017888462 date "2003-08-01" @default.
• W2017888462 modified "2023-09-27" @default.
• W2017888462 title "Topoisomerase IIα as a Marker Predicting the Efficacy of Anthracyclines in Breast Cancer: Are We at the End of the Beginning?" @default.
• W2017888462 cites W1262485082 @default.
• W2017888462 cites W1497849975 @default.
• W2017888462 cites W1550594329 @default.
• W2017888462 cites W1773921558 @default.
• W2017888462 cites W1791631034 @default.
• W2017888462 cites W1848579801 @default.
• W2017888462 cites W1853410251 @default.
• W2017888462 cites W1896390601 @default.
• W2017888462 cites W1919384911 @default.
• W2017888462 cites W1971215111 @default.
• W2017888462 cites W1972227366 @default.
• W2017888462 cites W1984732975 @default.
• W2017888462 cites W1987783969 @default.
• W2017888462 cites W1996982054 @default.
• W2017888462 cites W1999463736 @default.
• W2017888462 cites W2011932334 @default.
• W2017888462 cites W2012920290 @default.
• W2017888462 cites W2014403549 @default.
• W2017888462 cites W2015960413 @default.
• W2017888462 cites W2018093390 @default.
• W2017888462 cites W2022939574 @default.
• W2017888462 cites W2025491667 @default.
• W2017888462 cites W2030295874 @default.
• W2017888462 cites W2030796899 @default.
• W2017888462 cites W2031676888 @default.
• W2017888462 cites W2035332337 @default.
• W2017888462 cites W2036329178 @default.
• W2017888462 cites W2037964145 @default.
• W2017888462 cites W2050384397 @default.
• W2017888462 cites W2065169383 @default.
• W2017888462 cites W2081894694 @default.
• W2017888462 cites W2083338918 @default.
• W2017888462 cites W2089799642 @default.
• W2017888462 cites W2089923996 @default.
• W2017888462 cites W2094013376 @default.
• W2017888462 cites W2108292279 @default.
• W2017888462 cites W2113546227 @default.
• W2017888462 cites W2115171989 @default.
• W2017888462 cites W2129134252 @default.
• W2017888462 cites W2130920434 @default.
• W2017888462 cites W2140600345 @default.
• W2017888462 cites W2161552138 @default.
• W2017888462 cites W2164631611 @default.
• W2017888462 cites W2167167632 @default.
• W2017888462 cites W2415251093 @default.
• W2017888462 cites W2417845837 @default.
• W2017888462 cites W50210946 @default.
• W2017888462 cites W2737410802 @default.
• W2017888462 doi "https://doi.org/10.1016/s1526-8209(11)70623-1" @default.
• W2017888462 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14499010" @default.
• W2017888462 hasPublicationYear "2003" @default.
• W2017888462 type Work @default.
• W2017888462 sameAs 2017888462 @default.
• W2017888462 citedByCount "20" @default.
• W2017888462 countsByYear W20178884622012 @default.
• W2017888462 countsByYear W20178884622014 @default.
• W2017888462 countsByYear W20178884622018 @default.
• W2017888462 countsByYear W20178884622020 @default.
• W2017888462 crossrefType "journal-article" @default.
• W2017888462 hasAuthorship W2017888462A5041495974 @default.
• W2017888462 hasAuthorship W2017888462A5068108014 @default.
• W2017888462 hasConcept C121608353 @default.
• W2017888462 hasConcept C126322002 @default.
• W2017888462 hasConcept C143998085 @default.
• W2017888462 hasConcept C147897179 @default.
• W2017888462 hasConcept C202751555 @default.
• W2017888462 hasConcept C2776802502 @default.
• W2017888462 hasConcept C2780521871 @default.
• W2017888462 hasConcept C3019719930 @default.
• W2017888462 hasConcept C502942594 @default.
• W2017888462 hasConcept C530470458 @default.
• W2017888462 hasConcept C54355233 @default.
• W2017888462 hasConcept C71924100 @default.
• W2017888462 hasConcept C86803240 @default.
• W2017888462 hasConceptScore W2017888462C121608353 @default.
• W2017888462 hasConceptScore W2017888462C126322002 @default.
• W2017888462 hasConceptScore W2017888462C143998085 @default.
• W2017888462 hasConceptScore W2017888462C147897179 @default.
• W2017888462 hasConceptScore W2017888462C202751555 @default.
• W2017888462 hasConceptScore W2017888462C2776802502 @default.
• W2017888462 hasConceptScore W2017888462C2780521871 @default.
• W2017888462 hasConceptScore W2017888462C3019719930 @default.
• W2017888462 hasConceptScore W2017888462C502942594 @default.
• W2017888462 hasConceptScore W2017888462C530470458 @default.
• W2017888462 hasConceptScore W2017888462C54355233 @default.
• W2017888462 hasConceptScore W2017888462C71924100 @default.
• W2017888462 hasConceptScore W2017888462C86803240 @default.
• W2017888462 hasLocation W20178884621 @default.
• W2017888462 hasLocation W20178884622 @default.
• W2017888462 hasOpenAccess W2017888462 @default.
• W2017888462 hasPrimaryLocation W20178884621 @default.
• W2017888462 hasRelatedWork W1997306293 @default.
• W2017888462 hasRelatedWork W2005743726 @default.

• next